EE233 LONG-TERM OUTCOMES OF LENACAPAVIR PLUS OPTIMIZED BACKGROUND REGIMEN VERSUS OTHER TREATMENTS FOR MULTI-DRUG RESISTANT HIV VIA A COST-EFFECTIVENESS MODEL

Jul 1, 2022, 00:00
10.1016/j.jval.2022.04.481
https://www.valueinhealthjournal.com/article/S1098-3015(22)00682-9/fulltext
Title : EE233 LONG-TERM OUTCOMES OF LENACAPAVIR PLUS OPTIMIZED BACKGROUND REGIMEN VERSUS OTHER TREATMENTS FOR MULTI-DRUG RESISTANT HIV VIA A COST-EFFECTIVENESS MODEL
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)00682-9&doi=10.1016/j.jval.2022.04.481
First page :
Section Title :
Open access? : No
Section Order : 10426
Categories :
Tags :
Regions :
ViH Article Tags :